What's in a risk factor? “He who strikes the ball”

This publication has 29 references indexed in Scilit:

• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• New Evidence for Beneficial Effects of Statins Unrelated to Lipid Lowering
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
• Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
  New England Journal of Medicine, 2000
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial
  The American Journal of Cardiology, 1995
• Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.
  BMJ, 1992
• Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context
  Published by Elsevier ,1990